Nanomaterials for therapeutic drug delivery

Nanobiomaterials Handbook

Volumn , Issue , 2016, Pages 12-

  Jegadeesan, Dinesh ^a   Eswaramoorthy, M ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

THERAPEUTIC DRUG DELIVERY;

DRUG DELIVERY;

EID: 85051446692     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (179)

1. http://en.wikipedia.org/wiki/Trojan_War (2009).
2. Y. G. Yu, D. S. King, and Y. K. Shin. 1994. Insertion of a coiled-coil peptide from influenza virus hemagglutinin into membranes. Science 266: 274-276.
3. T. Shangguan, D. P. Siegel, J. D. Lear, P. H. Axelsen, D. Alford, and J. Bentz. 1998. Morphological changes and fusogenic activity of influenza virus hemagglutinin. Biophys. J. 74(1): 54-62.
4. R. Gref, Y. Minamatake, M. T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer. 1994. Biodegradable long-circulating polymeric nanospheres. Science 263: 1600-1603.
5. E. Soussan, S. Cassel, M. Blanzat, and I. R. Lattes. 2009. Drug delivery by soft matter: Matrix and vesicular carriers. Angew. Chem. Int. Ed. 48: 274-288.
6. V. P. Torchilin (Ed). 2006. Nanoparticulates as Drug Carriers. Imperial College Press, London, UK.
7. P. Couvreur, B. Kante, M. Roland, and P. Speiser. 1979. Adsorption of anti-neoplastic drugs to polyalkylcyanoacrylate nanoparticles and their release in calf serum. J. Pharm. Sci. 68(12): 1521-1524.
8. P. Couvreur. B. Kante, V. Lenaerts, V. Scailteur, M. Roland, and P. Speiser. 1980. Tissue distribution of anti-tumor drugs associated with polyalkylcyanoacrylate nanoparticles. J. Pharm. Sci. 69(2): 199-202.
9. D. Peer, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit, and R. Langer. 2007. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2(12): 751-760.
10. D. A. LaVan, T. McGuire, and R. Langer. 2003. Small-scale systems for in vivo drug delivery. Nat. Biotechnol. 21: 1184-1191.
11. D. A. Tomalia, H. Baker, M. Hall, G. Kallos, S. Martin, J. Roeck, J. Ryder, and P. Smith. 1985. A new class of polymers: Starburst-dendritic macromolecules. Polym. J. 17(1): 117-132.
12. M. Mammen, S. K. Choi, and G. M. Whitesides. 1998. Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angew. Chem. Int. Ed. 37: 2754-2794.
13. M. Liu and J. M. J. Fréchet.1999. Polym. Mater. Sci. Eng. 80: 167.
14. M. Liu, K. Kono, and J. M. J. Fréchet. 2000.Water-soluble dendritic unimolecular micelles: Their potential as drug delivery agents. J. Control. Release 65: 121-131.
15. J. Z. Hilt and M. E. Byrne. 2004. Configurational biomimesis in drug delivery: Molecular imprinting of biologically significant molecules. Adv. Drug Del. Rev. 56: 1599-1620.
16. N. A. Peppas, J. Z. Hilt, A. Khademhosseini, and R. Langer. 2006. Hydrogels in biology and medicine: From molecular principles to bionanotechnology. Adv. Mater. 18(11): 1345-1360.
17. K. Letchford and H. Burt. 2007. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: Micelles, nanospheres, nanocapsules and polymersomes. Eur. J. Pharm. Biopharm. 65: 259-269.
18. Y. H. Bae, T. Okano, and S. W. Kim. 1991. "On-Off" thermocontrol of solute transport. II solute release from thermosensitive hydrogels. Pharm. Res. 8: 624-628.
19. Y. H. Bae, T. Okano, and S. W. Kim. 1991. "On-Off" thermocontrol of solute transport. I. Temperature dependent swelling of N-isoprpylacrylamide networks modified with hydrophobic components in water. Pharm. Res. 8: 531-537.
20. S. H. Yuk, S. H. Cho, and S. H. Lee. 1997. pH/temperature-responsive polymer composed of poly(N,N-dimethylaminoethyl methacrylate-co-ethylacrylamide). Macromolecules 30: 6856-6859.
21. T. M. Allen, T. Mehra, C. Hansen, and Y. C. Chin. 1992. Stealth liposomes: An improved sustained release system for 1-β-D-arabinofuranosylcytosine. Cancer Res. 52(9): 2431-2439.
22. K. Ferrara, R. Pollard, and M. Borden. 2007. Ultrasound microbubble contrast agents: Fundamentals and application to gene and drug delivery. Ann. Rev. Biomed. Eng. 9: 415-447.
23. N. S. Chung and K. M. Vasan. 2004. Potential role of low density lipoprotein receptor family as mediators of cellular drug uptake. Adv. Drug Del. Rev. 56: 1315-1334.
24. A. J. Domb. 1993. Lipospheres for controlled delivery of substances. US patent No. 5188837.
25. A. J. Domb. 1995. Long acting injectable oxytetracycline-liposphere formulation. Int. J. Pharm. 124: 271-278.
26. A. J. Domb. 1993. Liposphere parenteral delivery system. Proc. Int. Symp. Control. Rel. Bioact. Mater. 20: 346-347.
27. A. Illing, T. Unruh, and M. H. J. Koch. 2004. Investigation on particle self-assembly in solid lipid based colloidal drug carrier systems. Pharm. Res. 21: 592-597.
28. K. Jores. 2007. Lipid nanodispersions as drug carrier systems-A physicochemical characterisation. Thesis University of Halle.
29. A. Illing and T. Unruh. 2004. Investigations on flow behavior of dispersions of solid triglyceride nanoparticles. Int. J. Pharm. 284: 123-131.
30. E. B. Souto et al. 2004. Evaluation of physical stability of SLN and NLC before and after incorporation into hydrogel formulations. Eur. J. Pharm. Biopharm. 58: 83-90.
31. H. Bunjes, K. Westesen, and M. H. J. Koch. 1996. Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int. J. Pharm. 129: 159-173.
32. W. Mehnert and K. Mäder. 2001. Solid lipid nanoparticles: Production, characterization and applications. Adv. Drug Del. Rev. 47: 165-196.
33. V. P. Torchilin. 2004. Targeted polymeric micelles for delivery of poorly soluble drugs. Cell Mol. Life Sci. 61: 2549-2559.
34. V. P. Torchilin. 2001. Structure and design of polymeric surfactant-based drug delivery systems. J. Control. Release 73: 137-172.
35. M. Antonietti and S. Forster. 2003. Vesicles and liposomes: A self-assembly principle beyond lipids. Adv. Mater. 15: 1323-1333.
36. B. Discher, Y. Y. Won, D. S. Ege, J. C. M. Lee, F. S. Bates, D. E. Discher, and D. A. Hammer. 1999. Polymerosomes: Tough vesicles made from diblock copolymers. Science 284: 1143-1146.
37. J. Z. Du and Y. M. Chen. 2004. Preparation of organic/inorganic hybrid hollow particles based on gelation of polymer vesicles. Macromolecules 37: 5710-5716.
38. I. Cho and Y. D. Kim. 1997. Synthesis and properties of tocopherol-containing polymeric vesicle system. Macromol. Symp. 118: 631-640.
39. I. Cho and Y. D. Kim.1998. Formation of stable polymeric vesicles by tocopherol containing amphiphiles. Macromol. Rapid Commun. 19: 27-30.
40. I. Cho and K. C. Chung. 1988. Cholesterol containing polymeric vesicles-Synthesis, characterization and separation as a solid powder. Macromolecules 21: 565-571.
41. M. D. Brown, A. Schatzlein, A. Brownline, V. Jack, W. Wang, L. Tetley, A. I. Gray, and I. F. Uchegbu. 2000. Preliminary characterization of novel amino acid based polymeric vesicles as gene and drug delivery agents. Bioconjug. Chem. 11(6): 880-891.
42. I. F. Uchegbu and A. T. Florence. 1995. Nonionic surfactant vesicles (niosomes)-Physical and pharmaceutical chemistry. Adv. Coll. Inter. Sci. 58: 1-55.
43. I. F. Uchegbu and S. P. Vyas. 1998. Nonionic surfactant vesicles (niosomes) in drug delivery. Int. J. Pharm. 172: 33-70.
44. L. Zarif. 2002. Elongated supramolecular assemblies in drug delivery. J. Control. Release Rev. 81: 7-23.
45. L. Zarif, J. R. Graybill, D. Perlin, and R. J. Mannino. 2000. Cochleates: New lipid-based drug delivery system. J. Liposome Res. 10(4): 523-538.
46. D. Papahadjopoulos, W. J. Wail, K. Jacobson et al. 1975. Cochleate lipid cylinders: Formation by fusion of unilamellar lipid vesicles. Biochim. Biophys. Acta 394: 483-491.
47. D. Papahadjopoulos. 1978. Large unilamellar vesicles and the method of preparing the same. US patent No. 4078052.
48. Z. P. Xu, H. Zeng, G. Qing Lu, and A. B. Yu. 2006. Inorganic nanoparticles as carriers for efficient cellular delivery. Chem. Eng. Sci. 61(3): 1027-1040.
49. P. K. Jain, X. Huang, I. H. El Sayed, and M. A. El Sayed. 2008. Nobel metals on the nanoscale: Optical and photothermal properties and some applications in imaging, sensing, biology and medicine. Acc. Chem. Res. 41: 1578-1586.
50. M. Hu, J. Chen, Z. L. Li, L. Au, G. V. Hartland, X. Li, M. Marquez, and Y. Xia. 2006. Gold nanostructures: Engineering their plasmonic properties for biomedical applications. Chem. Soc. Rev. 35(11): 1084-1094.
51. S. Eustis and M. A. El Sayed. 2006. Why gold nanoparticles are more precious than pretty gold: Noble metal surface plasmon resonance and its enhancement of the radiative and non radiative properties of nanocrystals of different shapes. Chem. Soc. Rev. 35(3): 209-217.
52. A. K. Salem, P. C. Searson, and K. W. Leong. 2003. Multifunctional nanorods for gene delivery. Nature Mat. 2: 668-671.
53. J. L. Bridot, D. Dayde, C. Riviére, C. Mandon, C. Billotey, S. Lerondel, R. Sabattier et al. 2009. Hybrid gadolinium oxide nanoparticles combining imaging and therapy. J. Mat. Chem. 19(16): 2328-2335.
54. A. Bianco and M. Prato. 2003. Can carbon nanotubes be considered useful tools for biological applications? Adv. Mat. 15: 1765-1768.
55. A. Bianco, K. Kostarelos, and M. Prato. 2005. Applications of carbon nanotubes in drug delivery. Curr. Opin. Chem. Bio. 9: 674-679.
56. N. W. S. Kam and H. Dai. 2005. Carbon nanotubes as intracellular protein transporters: Generality and biological functionality. J. Amer. Chem. Soc. 127: 6021-6026.
57. G. Jia, H. Wang, L. Yan, X. Wang R. Pei, T. Yan, Y. Zhao, and X. Guo. 2005. Cytotoxicity of carbon nanomaterials: Single wall nanotube, multiwall nanotube and fullerene. Environ. Sci. Technol. 39(5): 1378-1383.
58. R. Selvi, D. Jagadeesan, B. S. Suma, G. Nagashankar, M. Arif, K. Balasubrahmanyam, M. Eswaramoorthy, and T.K. Kundu. 2008. Intrinsically fluorescent carbon nanospheres as a nuclear targeting vector: Delivery of membrane-impermeable molecule to modulate gene expression in vivo. Nano Lett. 8(10): 3182-3188.
59. C. Barbe, J. Barlett, L. Kong, K. Finnie, H. Q. Lin, M. Larkin, S. Calleja, A. Bush, and G. Calleja. 2004. Silica particles: A novel drug delivery system. Adv. Mat. 16(21): 1959-1966.
60. A. Petri-Fink, M. Chastellain, L. Juillerat-Jeanneret, A. Ferrari, and H. Hofmann. 2005. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells. Biomaterials 26(15): 2685-2694.
61. Z. Tao, M. P. Morrow, T. Asefa, K. K. Sharma, C. Duncan, A. Anan, H. S. Penefsky, J. Goodisman, and A.K. Souid. 2008. Mesoporous silica nanoparticles inhibit cellular respiration. Nano Lett. 8(5): 1517-1526.
62. C. Loo, A. Lowrey, N. Halas, J. West, and R. Drezek. 2005. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett. 5(4): 709-711.
63. W. H. Suh et al. 2009. Multifunctional nanosystems at the interface of physical and life sciences. Nano Today 4: 27-36.
64. S. Pal, D. Jagadeesan, K. L. Gurunatha, M. Eswaramoorthy, and T. K. Maji. 2008. Construction of bi-functional inorganic-organic hybrid nanocomposites. J. Mat. Chem. 18(45): 5448-5451.
65. S. Fukushima, S. Kishimoto, Y. Takeuchi, and M. Fukushima. 2000. Preparation and evaluation of o/w type emulsions containing antitumor prostaglandin. Adv. Drug Del. Rev. 45(1): 65-75.
66. I. Danielsson and B. Lindman. 1981. The definition of a microemulsion. Coll. Surf. 3: 391-392.
67. A. Wretlind. 1999. The development of fat emulsions. Nutrition 15: 641-645.
68. R. Jeppsson and S. Ljungberg. 1975. Acta Pharmacol. Toxicol. 36: 312.
69. G. M. Tejado, S. Bouttier, J. Fourniat, J. L. Grossiord, J. P. Marty, M. Seiller. 2005. Release of antiseptics from the aqueous compartments of a w/o/w multiple emulsions. Int. J. Pharm. 288(1): 63-72.
70. F. Cournarie, M. P. Savelli, W. Rosilio, F. Bretez, C. Vauthier, J. L Grossiord, M. Seiller. 2004. Insulin-loaded W/O/W multiple emulsions: Comparison of the performances of systems prepared with medium-chain-triglycerides and fish oil. Eur. J. Pharm. Biopharm. 58(3): 477-482.
71. S. Higashi and T. Setoguchi. 2000. Hepatic arterial injection chemotherapy for hepatocellular carcinoma with epirubicin aqueous solution as numerous vesicles in iodinated poppy-seed oil microdroplets: Clinical application of water-in-oil-in-water emulsion prepared using a membrane emulsification technique. Adv. Drug Del. Rev. 45: 57-64.
72. B. D. Spiess. 2009. Perfluorocarbon emulsions as a promising technology: A review of tissue and vascular gas dynamics. J. Appl. Physiol. 106: 1444-1452.
73. E. Estephan, M. B. Saab, C. Larroque et al. 2009. Peptides for functionalization of InP semiconductors. J. Coll. Int. Sci. 337: 358-363.
74. C. J. Murphy, A. M. Gole, J. W. Stone et al. 2008. Gold nanoparticles in biology: Beyond toxicity to cellular imaging. Acc. Chem. Res. 41: 1721-1730.
75. A. Portis, C. Newton, W. Pangborn, and D. Papahajopoulous. 1979. Studies on the mechanism of membrane fusion: Evidence for an intermembrane Ca+2-phospholipid complex, synergism with Mg+2, and inhibition by spectrin. Biochemistry 18(5): 780-790.
76. L. Zhang, S. Qiao, Y. Jin, L. Cheng, Z. Yan, and G. Q. Lu. 2008. Hydrophobic functional group initiated helical mesostructured silica for controlled drug release. Adv. Funct. Mat. 18(23): 3834-3842.
77. J. J. Green, R. Langer, and D. G. Anderson. 2008. A Combinatorial polymer library approach yields insight into the nonviral gene delivery. Acc. Chem. Res. 41: 749-759.
78. Z. Adamczyk, B. Siwek, K. Jaszczolt, and P. Weroński. 2004. Deposition of latex particles on heterogenous surfaces. Coll. Surf. A Physicochem. Eng. Asp. 249(1-3): 95-98.
79. R. K. Jain. 2001. Delivery of molecular medicine to solid tumors: Lessons from in vitro imaging and gene expression and function. J. Control. Release 74: 7-25.
80. M. Sugihara-Seki and R. Skalak. 1997. Asymmetric flows of spherical particles in a cylindrical tube. Biorheology. 34: 155-159.
81. H. Wang and R. Skalak. 1969. Viscous flow in a cylindrical tube containing a line of spherical particles. J Fluid Mech. 38: 75-96.
82. B. Nasseri and A. T. Florence. 2003. Microtubules formed by capillary extrusion and fusion of surfactant vesicles. Int. J. Pharm. 266: 91-98.
83. D. Jagadeesan, U. Mansoori, P. Mandal, A. Sundaresan, and M. Eswaramoorthy. 2008. Hollow spheres to nanocups: Tuning the morphology and the magnetic properties of single crystalline a-Fe2O3 nanostructures. Angew. Chem. Int. Ed. 47: 7685-88.
84. J. B. Lassiter, M. W. Knight, N. A. Mirin, and N. J. Halas. 2009. Reshaping the plasmonic properties of a single nanoparticle. 2009. Nano Lett. 9(12): 4326-4332.
85. W. R. Bowen and A. Mongruel. 1998. Calculation and collective diffusion coefficient of electrostatically stabilised colloidal particles. Coll. Surf. A. 138: 161-172.
86. I. F. Uchegbu et al. 1997. Polyhedral non ionic surfactant vesicles. J Pharm. Pharmacol. 49: 606-610.
87. R. Vasanthi and S. Battacharya. 2005. Anisotropic diffusion of spheroids in liquids: Slow orientational relaxation of the oblates. J. Chem. Phys. 116: 1092-1096.
88. Y. Geng, P. Dalhaimer, S. Cai, R. Tsai, M. Tewari, T. Minko, and D. E. Discher. 2007. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nanotech. 2(2): 249-255.
89. Z. Adamczyk, B. Siwek, K. Jaszczólt, and P. Weroński. 2004. Deposition of latex particles at heterogenous surfaces. Coll. Surf. A Physicochem. Eng. Asp. 249(1-3): 95-98.
90. D. B. Warheit, B. R. Laurence, K. L. Reed, D. H. Roach, G. A. M. Reynolds, and T. R. Webb. 2004. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci. 77(1): 117-125.
91. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori. 2000. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J Control. Release 65: 271-284.
92. H. Maeda, T. Sawa, and T. Konno. 2001. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J. Control. Release 74: 47-61.
93. M. Marsh and H. T. McMahon. 1999. The structural era of endocytosis. Science 285: 215-219.
94. S. D. Conner and S. L. Schmid. 2003. Regulated portals of entry into the cell. Nature 422: 37-44.
95. K. Kostarelos, L. Lacerda, G. Pastorin, W. Wu, S. Wieckowski, J. Luangsivilay, S. Godefroy, D. Pantarotto, J. P. Briand, S. Muller, M. Prato, and A. Bianco. 2007. Cellular uptake of functionalised carbon nanotubes is independent of functional group and cell type. Nat. Nanotech. 2(2): 108-113.
96. N. W. S. Kam, Z. Liu, and H. Dai. 2006. Carbon nanotubes as intracellular transporters for proteins and DNA: An investigation of the uptake mechanism and pathway. Angew. Chem. Int. Ed. 45: 577-581.
97. S. Muro, M. Koval, and V. Muzykantov. 2004. Endothelial endocytotic pathways: Gates for vascular drug delivery. Curr. Vasc. Pharmacol. 2: 281-299.
98. M. L. Hedley, J. Curley, and R. Urban. 1998. Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses. Nat Med. 4: 365-368.
99. G. Hermanson. 1996. Bioconjugate Techniques. Academic Press Inc., San Diego, CA, pp. 570-592.
100. T. Merdan, J. Kopecek, and T. Kissel. 2002. Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv. Drug Del. Rev. 54(5): 715-758.
101. M. Roser, D. Fischer, and T. Kissel. 1998. Surface-modified biodegradable albumin nano and microspheres II. Effect of surface charges on in vitro phagocytosis and biodistribution in rats. Eur. J. Pharm. Biopharm. 46: 255-263.
102. T. I. Armstrong, S. M. Moghimi, S. S. Davis, and L. Illum. 1997. Activation of mononuclear phagocyte system by poloxamine 908: Its implications for targeted drug delivery. Pharm Res. 14: 1629-1633.
103. J. Vandorpe, E. Schaht, S. Dunn, A. Hawley, S. Stolnik, S. S. Davis, M. C. Garnett, M. C. Davies, L. Illum. 1997. Long-circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene) and poly(ethyleneoxide) copolymer. Biomaterials 18(17): 1147-1152.
104. J. C. Neal et al. 1998. Modification of the copolymers polaxomer 407 and poloxamine 908 can affect the physical and biological properties of surface modified nanospheres. Pharm Res. 15: 324-328.
105. S. Medda, P. Jaisankar, R. K. Manna et al. 2003. Phospholipid microspheres: A novel delivery mode for targeting antileishmanial agent in experimental leishmaniasis. J. Drug Targ. 11: 123-128.
106. S. M. Moghimi, A. E. Hawley, N. M. Christy, T. Gray, L. Illum, and S. S. Davis. 1994. Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes. FEBS Lett. 344(1): 25-30.
107. A. E. Hawley, L. Illum, and S. S. Davis. 1997. Lymph node localization of biodegradable nanospheres surface modified with poloxamer and poloxamine block copolymers. FEBS Lett. 400(3): 319-323.
108. A. E. Hawley, L. Illum, and S. S. Davis. 1997. Preparation of biodegradable surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake. Pharm Res. 14: 657-661.
109. J. M. Harris. 1992. Poly(ethyleneglycol) Chemistry: Biotechnical and Biomedical Applications. Plenum Press: New York.
110. A. Benigni, S. Tomasoni, and G. Remuzzi. 2002. Impediments to successful gene transfer to the kidney in the context of transplantation and how to overcome them. Kidney Int. 61: 115-119.
111. M. Brightman. 1992. Ultrastructure of the brain endothelium. M.W.B. Bradbury (ed.) Physiology and the Pharmacology of the Blood Brain Barrier. Handbook of Experimental Pharmacology. Springer: Berlin, Heidelberg, vol. 103, pp. 1-22.
112. J. Kreuter. 2001. Nanoparticle systems for brain delivery of drugs. Adv. Drug Del. 47: 65-81.
113. J. Kreuter. 2002. Transport of drugs across the blood brain barrier by the nanoparticles. Curr. Med. Chem. Cent. Nerv. Sys. Agents 2: 241-249.
114. A. Szewczyk and L. Wojtczak. 2002. Pharmacol. Rev. 54: 101-127.
115. G. G. D`Souza, S. V. Boddapati, and V. Weissig. 2005. Mitochondrial leader sequence-plasmid DNA conjugates delivered into mammalian cells by DQAsomes co-localize with mitochondria. Mitochondrion 5: 352-358.
116. F. Rodriguez, L. L. An, S. Harkins et al. 1998. DNA immunization with minigenes: Low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination. J. Virol. 72: 5174-5181.
117. F. Rodriguez, J. Zhang, and J. L. Whitton. 1997. DNA immunization: Ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction. J. Virol. 71: 8497-8503.
118. G. Delogu, A. Howard, F. M. Collins, and S. L. Morris. 2000. DNA vaccination against tuberculosis: Expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity. Infect. Immun. 68: 3097-3102.
119. T. Tobery and R. F. Siliciano. 1999. Cutting edge: Induction of enhanced CTL-dependent protective immunity in vivo by N-end rule targeting of a model tumor antigen. J. Immunol. 162: 639-642.
120. S. Brunner, E. Furtbauer, T. Sauer, M. Kursa, and E. Wagner. 2002. Overcoming the nuclear barrier: Cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation. Mol. Ther. 5(1): 80-86.
121. W. T. Godbey, K. K. Wu, and A. G. Mikos. 1999. Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc. Natl. Acad. Sci. USA 96: 5177-5181.
122. L. J. Branden, A. J. Mohamed, and C. I. Smith, 1999. Peptide nucleic acid-nuclear localization signal fusion that mediates nuclear transport of DNA. Nat. Biotechnol. 17: 784-787.
123. M. A. Zanta, P. Belguise-Valladier, and J. P. Behr. 1999. Gene delivery: A single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc. Natl. Acad. Sci. USA 96: 91-96.
124. C. K. Chan and D. A. Jans. 1999. Enhancement of polylysine-mediated transfection by nuclear localization sequences (NLSs): Polylysine does not function as an NLS. Hum. Gene Ther.10: 1695-1702.
125. C. W. Pouton. 1998. Nuclear import of polypeptides, polynucleotides and supramolecular complexes. Adv. Drug Del. Rev. 34: 51-64.
126. R. A. Smith, C. M. Porteous, A. M. Gane, and M. P. Murphy. 2003. Delivery of bioactive molecules to mitochondria in vivo. Proc. Natl. Acad. Sci. USA 100(9): 5407-5412.
127. M. P. Murphy and R. A. Smith. 2000. Drug delivery to mitochondria: The key to mitochondrial medicine. Adv. Drug Del. Rev. 41: 235-250.
128. A. Muratovska, R. N. Lightowlers, R. W. Taylor, J. A. Wilce, and M. P. Murphy. 2001. Targeting large molecules to mitochondria. Adv. Drug Del. Rev. 49(1-2): 189-198.
129. A. Szewczyk and L. Wojtczak. 2002. Mitochondria as a pharmacological target. Pharmacol. Rev. 54: 101-127.
130. A. Weissig, J. Lasch, G. Erdos et al. 1998. DQAsomes: A novel potential drug and gene delivery system made from dequalinium. Pharm. Res. 15: 334-337.
131. N. K. Subbarao, R. A. Parente, F. C. Szoka, Jr, L. Nadasdi, and K. Pongracz. 1987. The pH dependent bilayer destabilization by an amphipathic molecule. Biochemistry 26(11): 2964-2972.
132. E. Wagner, C. Plank, K. Zatloukal, M. Cotten, and M. L. Bimstiel. 1992. Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: Toward a synthetic virus-like gene-transfer vehicle. Proc. Natl. Acad. Sci. USA 89(17): 7934-7938.
133. J. Haensler and F. C. Szoka, Jr. 1993. Polyamidoamine cascade polymers mediate transfection of cells in culture. Bioconjugate Chem. 4: 372-379.
134. O. Boussif, F. Lezoualc`h, M. A. Zanta, M. D. Mergny, D. Scherman, B. Demeneix, and J. P. Behr. 1995. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc. Natl. Acad. Sci. USA 92(16): 7297-7301.
135. T. Merdan, K. Kunath, D. Fischer et al. 2002. Intracellular processing of -poly(ethylene imine)/ribozyme complexes can be observed in living cells using confocal laser scanning microscopy and inhibitor experiments. Pharm. Res. 19: 140-146.
136. A. Akinc, M. Thomas, A. M. Klibanov, and R. Langer. 2005. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J. Gene Med. 7: 657-663.
137. M. X. Tang, C. T. Redemann, and F. C. Szoka, Jr. 1996. In vitro gene delivery by dragged polyamidoamine dendrimers. Bioconjugate Chem. 7: 703-714.
138. W. T. Godbey, M. A. Barry, P. Saggau, K. K. Wu, and A. G. Mikos. 2000. Poly(ethyleneimine) mediated transfection: A new paradigm for gene delivery. J. Biomed. Mater. Res. 51(3): 321-328.
139. B. Neukamm, A. Weimann, S. Wu, M. Danevad, C. Lang, and R. Gebner. 2006. Novel two stage screening procedure leads to the identification of a new class of transfection enhancers. J. Gene Med. 8(6): 745-753.
140. C. C. Mello and D. Conte Jr. 2004. Revealing the world of RNA interference. Nature 431: 338-342.
141. V. Sokolova and M. Epple. 2007. Inorganic nanoparticles as carriers of nucleic acids into cells. Angew. Chem. Int. Ed. 47: 1382-1395.
142. E. Wagner, C. Plank, K. Zatloukal, M. Cotten, and M. L. Bimstiel. 1992. Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: Toward a synthetic virus-like gene-transfer vehicle. Proc. Natl. Acad. Sci. USA 89(17): 7934-7938.
143. M. A. Wolfert, P. R. Dash, O. Nazarova, and D. Oupicky. 1999. Polyelectrolyte vectors for gene delivery: Influence of cationic polymer on biophysical properties of complexes formed with DNA. Bioconjugate Chem. 10: 993-1004.
144. R. Kircheis, L. Wightman, and E. Wagner. 2001. Design and gene delivery activity of modified polyethylenimines. Adv. Drug Del. Rev. 53: 341-358.
145. S. Kazuyoshi and S. W. Kim. 2002. Multipulse drug permeation across a membrane driven by a chemical pH-oscillator. J. Control. Release 79: 271-281.
146. C. Rudolph, U. Schillinger, and C. Plank. 2002. Nonviral gene delivery to the lung with copolymer-protected and transferrin-modified polyethylenimine. Biochim. Biophys. Acta 1573: 75-83.
147. D. G. Anderson, D. M. Lynn, and R. Langer. 2003. Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery. Angew. Chem. Int. Ed. 42: 3153-3158.
148. G. Schmid. 1992. Large clusters and colloids: Metals in the embryonic state. Chem. Rev. 92: 1709-1727.
149. M. Oishi, J. Nakaogami, T. Ishii, and Y. Nagasaki. 2006. Smart PEGylated gold nanoparticals for the cytoplasmic delivery of siRNA to induce enhanced gene silencing. Chem. Lett. 35: 1046-1047.
150. N. L. Rosi, D. A. Giljohann, C. S. Thaxton, A. K. R. Lytton-Jean, M. S. Han, and C. A. Mirkin. 2006. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 312: 1027-1030.
151. Z. Liu, M. Winters, M. Holodniy, and H. Dai. 2007. siRNA Delivery into Human T Cells and primary cells with carbon-nanotube transporters. Angew. Chem. Int. Ed. 46: 2023-2027.
152. P. Gould. 2004. Nanoparticles probe biosystems. Mater. Today 7: 36-43.
153. I. J. Bruce, J. Taylor, M. Todd, M. J. Davies, E. Borioni, C. Sangregorio, and T. Sen. 2004. Synthesis, characterisation and application of silica-magnetite nanocomposites. J. Magn. Magn. Mater. 284: 145-160.
154. A. Campo, T. Sen, J. P. Lellouche, and I. J. Bruce. 2005. Multifunctional magnetite and silica-magnetite nanoparticles: Synthesis, surface activation and applications in life sciences. J. Magn. Magn. Mater. 293: 33-40.
155. N. Morishita, H. Nakagami, R. Morishita et al. 2005. Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector. Biochem. Biophys. Res. Commun. 334: 1121-1126.
156. D. Luo and W. M. Saltzman. 2000. Enhancement of transfection by physical concentration of DNA at the cell surface. Nat. Biotechnol. 18: 893-895.
157. R. A. Gemeinhart, D. Luo, and W. M. Saltzman. 2005. Cellular fate of a modular DNA delivery system mediated by silica nanoparticles. Biotechnol. Prog. 21: 532-537.
158. H. Shen, J. Tan, and W. M. Saltzman. 2004. Surface-mediated gene transfer from nanocomposites of controlled texture. Nat. Mater. 3: 569-574.
159. F. L. Graham and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52: 456-467.
160. A. Maitra. 2005. Calcium phosphate nanoparticles: Second-generation nonviral vectors in gene therapy. Expert Rev. Mol. Diagn. 5: 893-905.
161. Y. Kakizawa and K. Kataoka. 2002. Block copolymer self-assembly into monodispersive nanoparticles with hybrid core of antisense DNA and calcium phosphate. Langmuir 18: 4539-4543.
162. D. Olton, J. Li, M. E. Wilson. T. Rogers, J. Close, L. Huang, P. N. Kumta, and C. Sfeir. 2007. Nanostructured calcium phosphates (NanoCaPs) for non-viral gene delivery: Influence of the synthesis parameters on transfection efficiency. Biomaterials 28(6): 1267-1279.
163. S. Aisawa, H. Hirahara, K. Ishiyama, W. Ogasawara, Y. Umetsu, and E. Narita. 2003. Sugar-anionic clay composite materials: Intercalation of pentoses in layered double hydroxide. J Solid State Chem. 174(2): 342-348.
164. B. Li, J. He, D. G. Evans, and X. Duan. 2004. Inorganic layered double hydroxides as a drug delivery system-intercalation and in vitro release of fenbufen. Appl. Clay Sci. 27: 199-207.
165. J. H. Choy, S. Y. Kwak, Y. J. Jeong, and J. S. Park. 2000. Inorganic layered double hydroxides as non viral vectors. Angew. Chem. Int. Ed. 39: 4041-4045.
166. H. M. Kipen and D. L. Laskin. 2005. Smaller is not always better: Nanotechnology yields nanotoxicology. Am. J. Physiol: Lung Cell. Mol. Physiol. 289: L696-L697.
167. N. Lewinski, V. Colvin, and R. Drezek. 2008. Cytotoxicity of nanoparticles. Small 4: 26-49.
168. M. Tarantola, D. Schneider, E. Sunnick, H. Adam, S. Pierrat, C. Rosman, V. Breus, C. Sonnichsen, T. Basche, J. Wegener, and A. Janshoff. 2009. Cytotoxicity of metal and semiconductor nanoparticles indicated by cellular micromotility. ACS Nano 3(1): 213-222.
169. Y. Pan, S. Neuss, A. Leifert, M. Fischler, F. Wen, U. Simon, G. Schmid, W. Brandau, and W. Jahnen-Dechent. 2007. Size-dependent toxicity of gold nanoparticles. Small 3(11): 1941-1949.
170. A. Magrez, S. Kasas. V. Salicio, N. Pasquier, J. W. Seo, M. Celio, S. Catsicas, B. Schwaller, and L. Forró. 2006. Cellular toxicity of carbon based nanomaterials. Nano Lett. 6(6): 1121-1125.
171. C. M. Sayes, A. M. Marchione, K. L. Reed, and D. B. Warheit. 2007. Comparative pulmonary toxicity assessments of C60 water suspensions in rats: Few differences in fullerene toxicity in vivo in contrast to in vitro profiles. Nano Lett. 7(8): 2399-2406.
172. A. Nan, X. Bai, S. J. Son, S. B. Lee, and H. Ghandehari. 2008. Cellular uptake and cytotoxicity of silica nanotubes. Nano Lett. 8(8): 2150-2154.
173. L. Ding, J. Stilwell, T. Zhang, O. Elboudwarej, H. Jiang, J. P. Selegue, P. A. Cooke, J. W. Gray, and F. F. Chen. 2005. Molecular characterisation of the cytotoxic mechanism of multiwall carbon nanotubes and nano onions on human skin fibroblasts. Nano Lett. 5(12): 2448-2464.
174. J. Miyawaki, M. Yudasaka, T. Azami Y. Kubo, and S. Iijima. 2008. Toxicity of single walled carbon nanohorns. ACS Nano 2(2): 213-226.
175. A. M. Derfus, W. C. W. Chan, and S. N. Bhatia. 2004. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett. 4(1): 11-18.
176. C. M. Sayes, J. D. Fortner, W. Guo, D. Lyon, A. M. Boyd, K. D. Ausman, Y. J. Tao et al. 2004. The differential cytotoxicity of water soluble fullerenes. Nano Lett. 4(10): 1881-1887.
177. G. Bhabra, A. Sood, B. Fisher, L. Cartwright, M. Saunders, W. H. Evans, A. Surprenant et al. 2009. Nanoparticles can cause DNA damage across a cellular barrier. Nature Nanotech. 4: 876-883.
178. J. M. Worle-Knirsch, K. Pulskamp, and H. F. Krug. 2006. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett. 6(6): 1261-1268.
179. J. S. Patton. 2006. A historical perspective on convergence technology. Nature Biotech. 24(3): 280-281.